Identification of sumoylated targets in proliferating mouse spermatogonia and human testicular seminomas

Abstract

ORIGINAL ARTICLE Identification of sumoylated targets in proliferating mouse spermatogonia and human testicular seminomas

Vigodner, Margarita1,2,; Lucas, Benjamin1; Kemeny, Stav1; Schwartz, Tamar1; Levy, Rebecca1 Author Information

1Department of Biology, Stern College, Yeshiva University, New York, NY 10016, USA

2Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA

Correspondence: Dr. M Vigodner (vigodner@yu.edu)

Received September 27, 2019

Accepted January 17, 2020 Asian Journal of Andrology 22(6):p 569-577, Nov–Dec 2020. | DOI: 10.4103/aja.aja_11_20

Open

Abstract

Spermatogenesis is regulated by a complex network of posttranslation modifications. Sumoylation (a modification by small ubiquitin-like modifiers, or SUMO proteins) was identified as an important cellular event in different cell types. SUMO proteins are highly expressed in the testis, and their role during spermatogenesis has begun to be elucidated. Given the important role of sumoylation in the regulation of mitosis and cancer progression in other tissues, the aim of the current study was to identify the targets of SUMO in proliferating mouse spermatogonia and human seminoma tissues and to initially examine the level of sumoylation in relation to the proliferative activity of the tissues. Using freshly purified spermatogonia and C18-4 spermatogonia cell line, mass spectrometry analysis identified several SUMO targets implicated into the proliferation of spermatogonia (such as heat shock protein 60 [HSP60] and prohibitin). Tissue array and western blot approaches showed that SUMO expression is a prominent feature of human seminomas and that the proliferative activity of the tumor tissues was positively correlated with the level of SUMO expression. Downregulation of sumoylation with si-RNA was not sufficient to significantly affect the proliferation of C18-4 spermatogonia; however, SUMO overexpression increased the proliferation rate of the cells. These data suggest that cells are more sensitive to an elevated level of SUMO, and that this situation may lead to an upregulated cellular proliferation and, possibly, cancer. Mass spectrometry analysis identified around a hundred SUMO targets in seminoma samples. Notably, many of the identified proteins (such as proliferating cell nuclear antigen [PCNA], DNA topoisomerase 2-alpha [Top2A], prohibitin, 14-3-3 protein, and others) were implicated in oncogenic transformation and cancer progression.